Allergan Inc. (AGN)'s CEO Insight: Stemming the Tide of Illegal Importation and Counterfeiting
8/26/2013 8:15:34 AM
The tide of counterfeit and illegally imported drugs and medical devices continues to be strong, as difficult economic times drives demand for seemingly cheaper alternatives. The sophistication of the counterfeiters and illegal importers makes this an increasingly difficult battle to wage, but the threat these illegally imported drugs pose to consumers is real, making it essential that government agencies, with support from industry, continue efforts to help battle this issue. We saw a clear example of this earlier this year when the international police agency Interpol announced a three-year funding commitment from more than two dozen pharmaceutical companies to support Interpol's Pharmaceutical Crime Program.
Help employers find you! Check out all the jobs and post your resume.
comments powered by